Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Overman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Epidemiology|May 23, 2020
Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United StatesLeah J McGrath, Karynsa Kilpatrick, Robert A Overman, et al.
Clinical Epidemiology|October 6, 2018
Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the USLeah J McGrath, Robert A Overman, Diane Reams, et al.
Journal of the Pediatric Infectious Diseases Society|December 26, 2023
Trends in Pediatric Emergency and Inpatient Healthcare Use for Mental and Behavioral Health Among North Carolinians During the Early COVID-19 PandemicRachel Sielaty, Angelique E Boutzoukas, Kanecia O Zimmerman, et al.
Journal of the American Heart Association|April 25, 2020
Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor InitiationJennifer A Rymer, Katherine E Mues, Keri L Monda, et al.
Pharmacoepidemiology and Drug Safety|January 10, 2018
Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United StatesAnne M Butler, Karynsa Cetin, Rohini K Hernandez, et al.
The American Journal of Medicine|March 13, 2017
Time to Clinically Relevant Fracture Risk Scores in Postmenopausal WomenMargaret L Gourlay, Robert A Overman, Jason P Fine, et al.
Menopause (New York, N.Y.)|October 29, 2014
Baseline age and time to major fracture in younger postmenopausal womenMargaret Lee Gourlay, Robert A Overman, Jason P Fine, et al.
Archives of Osteoporosis|November 9, 2017
Correction to: Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS studyMargaret L Gourlay, Victor S Ritter, Jason P Fine, et al.
Archives of Osteoporosis|October 21, 2017
Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS studyMargaret L Gourlay, Victor S Ritter, Jason P Fine, et al.
American Journal of Preventive Medicine|January 30, 2016
Time to Osteoporosis and Major Fracture in Older Men: The MrOS StudyMargaret L Gourlay, Robert A Overman, Jason P Fine, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Epidemiology|May 23, 2020
Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United StatesLeah J McGrath, Karynsa Kilpatrick, Robert A Overman, et al.
Clinical Epidemiology|October 6, 2018
Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the USLeah J McGrath, Robert A Overman, Diane Reams, et al.
Journal of the Pediatric Infectious Diseases Society|December 26, 2023
Trends in Pediatric Emergency and Inpatient Healthcare Use for Mental and Behavioral Health Among North Carolinians During the Early COVID-19 PandemicRachel Sielaty, Angelique E Boutzoukas, Kanecia O Zimmerman, et al.
Journal of the American Heart Association|April 25, 2020
Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor InitiationJennifer A Rymer, Katherine E Mues, Keri L Monda, et al.
Pharmacoepidemiology and Drug Safety|January 10, 2018
Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United StatesAnne M Butler, Karynsa Cetin, Rohini K Hernandez, et al.
The American Journal of Medicine|March 13, 2017
Time to Clinically Relevant Fracture Risk Scores in Postmenopausal WomenMargaret L Gourlay, Robert A Overman, Jason P Fine, et al.
Menopause (New York, N.Y.)|October 29, 2014
Baseline age and time to major fracture in younger postmenopausal womenMargaret Lee Gourlay, Robert A Overman, Jason P Fine, et al.
Archives of Osteoporosis|November 9, 2017
Correction to: Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS studyMargaret L Gourlay, Victor S Ritter, Jason P Fine, et al.
Archives of Osteoporosis|October 21, 2017
Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS studyMargaret L Gourlay, Victor S Ritter, Jason P Fine, et al.
American Journal of Preventive Medicine|January 30, 2016
Time to Osteoporosis and Major Fracture in Older Men: The MrOS StudyMargaret L Gourlay, Robert A Overman, Jason P Fine, et al.
Pageof 2